导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -18.88% | 4312/4773 |
| 近一周 | -3.16% | 4600/5465 |
| 近一月 | 0.91% | 406/5421 |
| 近一季 | -6.13% | 2294/5231 |
| 近半年 | -21.78% | 4470/4920 |
| 近一年 | -5.50% | 3179/4394 |
| 近两年 | 26.33% | 2445/2954 |
| 近三年 | -3.72% | 1977/2253 |
| 成立以来 | 62.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.29% 3112/4961 |
-9.33% 3955/5312 |
- - |
- - |
| 2025 | 25.77% 1686/4813 |
-3.85% 3092/3635 |
15.87% 33/4076 |
4.93% 3634/4524 |
7.59% 291/4813 |
| 2024 | 3.62% 1915/3463 |
-11.36% 2427/2808 |
2.11% 400/3014 |
13.16% 2230/3129 |
1.17% 1111/3463 |
| 2023 | -18.17% 1785/2656 |
-4.63% 2111/2280 |
0.30% 329/2385 |
-9.05% 1772/2515 |
-5.95% 1567/2655 |
| 2022 | -28.77% 1580/2207 |
-23.02% 1721/1919 |
3.59% 1127/2016 |
-8.23% 183/2113 |
-2.67% 1811/2208 |
| 2021 | 13.54% 353/1822 |
-17.50% 1201/1255 |
12.04% 350/1330 |
6.10% 244/1466 |
15.77% 57/1822 |
| 2020 | 73.66% 60/1250 |
-6.63% 501/1028 |
14.40% 554/1067 |
30.71% 9/1164 |
24.38% 36/1184 |
| 2019 | - - |
- - |
- - |
- - |
2.40% 865/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 富国中证军工龙头ETF VS. 长安沪深300非周期A(740101) |